Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: J Comp Neurol. 2022 Apr 9;530(12):2100–2112. doi: 10.1002/cne.25322

Table 2.

Details on the antibodies used in the present study.

ANTIBODY TARGET SPECIES CONCENTRATION SOURCE
PRIMARIES Parvalbumin (PV) GUINEA PIG 1:1000 or 2 μg/mL Synaptic Systems (Cat# 195–004, RRID:AB_2156476)
Glucocorticoid Receptor (GR) RABBIT 1:800 or 6.5 μ/mL Thermo Fisher Scientific (Cat# PA5–21341, RRID:AB_11152512)
Somatostatin (SST) RAT 1:200 or 10 μ/mL Millipore Sigma (Cat# MAB354, RRID:AB_2255365)
Enhanced green fluorescent protein (eGFP) CHICKEN 1:500 or 4 μ/mL Abcam (Cat# AB13970, RRID:AB_300798)
Highly Cross-Adsorbed
SECONDARIES
Alexa Fluor 647 antiguinea pig IgG (H+L) GOAT 1:1000 or 2 μ/mL Invitrogen by Thermo Fisher Scientific (Cat# A-21450, RRID:AB_2735091)
Alexa Fluor 647 anti-rabbit IgG (H+L) GOAT 1:1000 or 2 μ/mL Invitrogen by Thermo Fisher Scientific (Cat# A-21244, RRID:AB_2535812)
Alexa Fluor 568 antirat (H+L) GOAT 1:1000 or 2 μ/mL Invitrogen by Thermo Fisher Scientific (Cat# A-11077, RRID:AB_2534121)
Alexa Fluor 488 antichicken (H+L) GOAT 1:1000 or 2 μ/mL Invitrogen by Thermo Fisher Scientific (Cat# A-32931, RRID:AB_2762843)